banner

Under 40 Community

Young patients face unique challenges when dealing with a breast cancer diagnosis. Hear how young breast cancer survivors personalized their care with tools like the Oncotype DX genomic test.

Take Charge of Your Health

Take Charge of Your Health

Share the Message

Share images on Instagram, Facebook, Twitter or Pinterest, and tag them with #NoMatterMyAge to help us get the word out.

Share Your Story

Know the Facts

Genomic testing rates in patients under 40 go down 1.5-fold compared to older patients3

Age shouldn’t affect your chances of getting the right breast cancer treatment. Yet an analysis from the National Cancer Institute’s (NCI) Surveillance, Epidemiology, and End Results (SEER) Registry revealed that patients under 40 were less likely to get a genomic test compared to patients 40-70 years of age.3 Talk to your doctor about your care, including whether or not a genomic test may help determine the best treatment plan for you – no matter your age.

Know the Facts

Patients Deserve to Know if They Need Chemotherapy or Not

Breast cancer is the most common cancer in young women2, yet most of these women don’t have all the information they need about their diagnosis when making a treatment decision. Ask questions and learn as much as you can about your cancer, including your personalized genomic test result. When you have all the information about your breast cancer, you can make the treatment decision that’s best for you.

Know the Facts

A Genomic Test Can Help Prevent Over-Treatment in Some Young Women with Breast Cancer*

While it’s been shown that young women are more likely to develop aggressive forms of breast cancer4, not all young women are the same. The Oncotype DX test helps patients determine their risk of distant recurrence and whether chemotherapy is necessary in addition to hormone therapy. Have a conversation with your doctor to learn how a genomic test can help you better understand and personalize your treatment options.

*Women with early stage, hormone receptor-positive, HER2-negative breast cancer

Know the Facts

~50% of Oncotype DX Patients Under 50 Do Not Need Chemotherapy6

For some patients, chemotherapy can help reduce the risk of breast cancer coming back. However, in a recent analysis of Oncotype DX patients under 50 years of age, nearly half did not need chemotherapy. Based on numerous studies and the landmark TAILORx trial of over 10,000 women worldwide, the Oncotype DX test helps patients and their doctors understand whether they need chemotherapy or not.1 If you want to know, ask your doctor for your genomic test result.

Know the Facts

Having personalized information is the best way a breast cancer patient can make treatment decisions with confidence

Breast cancer treatment today is no longer “one size fits all”—what is best for one woman may not be right for another – but understanding all your options can be overwhelming. You can take charge of your care by learning as much as you can about your diagnosis and asking your doctor about getting a genomic test result to help make a personalized treatment decision with confidence.

Know the Facts

Genomic testing rates in patients under 40 go down 1.5-fold compared to older patients3

Age shouldn’t affect your chances of getting the right breast cancer treatment. Yet an analysis from the National Cancer Institute’s (NCI) Surveillance, Epidemiology, and End Results (SEER) Registry revealed that patients under 40 were less likely to get a genomic test compared to patients 40-70 years of age.3 Talk to your doctor about your care, including whether or not a genomic test may help determine the best treatment plan for you – no matter your age.

Patients Deserve to Know if They Need Chemotherapy or Not

Breast cancer is the most common cancer in young women2, yet most of these women don’t have all the information they need about their diagnosis when making a treatment decision. Ask questions and learn as much as you can about your cancer, including your personalized genomic test result. When you have all the information about your breast cancer, you can make the treatment decision that’s best for you.

A Genomic Test Can Help Prevent Over-Treatment in Some Young Women with Breast Cancer*

While it’s been shown that young women are more likely to develop aggressive forms of breast cancer4, not all young women are the same. The Oncotype DX test helps patients determine their risk of distant recurrence and whether chemotherapy is necessary in addition to hormone therapy. Have a conversation with your doctor to learn how a genomic test can help you better understand and personalize your treatment options.

*Women with early stage, hormone receptor-positive, HER2-negative breast cancer

~50% of Oncotype DX Patients Under 50 Do Not Need Chemotherapy6

For some patients, chemotherapy can help reduce the risk of breast cancer coming back. However, in a recent analysis of Oncotype DX patients under 50 years of age, nearly half did not need chemotherapy. Based on numerous studies and the landmark TAILORx trial of over 10,000 women worldwide, the Oncotype DX test helps patients and their doctors understand whether they need chemotherapy or not.1 If you want to know, ask your doctor for your genomic test result.

Having personalized information is the best way a breast cancer patient can make treatment decisions with confidence

Breast cancer treatment today is no longer “one size fits all”—what is best for one woman may not be right for another – but understanding all your options can be overwhelming. You can take charge of your care by learning as much as you can about your diagnosis and asking your doctor about getting a genomic test result to help make a personalized treatment decision with confidence.

Patient Stories

Patient Resources

Helpful patient organizations for you or your loved one facing a breast cancer diagnosis

Additional Readings

Learn more about the age bias issues in genomic testing and treatments for breast cancer patients

If you have been diagnosed with early-stage invasive breast cancer, MyBreastCancerTreatment can help you overcome challenges of understanding your diagnosis by providing information and treatment options.